Your browser doesn't support javascript.
loading
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
Liu, Lian; Erickson, Nicole Tonya; Ricard, Ingrid; von Weikersthal, Ludwig Fischer; Lerch, Markus M; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Höffkes, Heinz-Gert; Moehler, Markus; Gesenhues, Alena Britta; Theurich, Sebastian; Michl, Marlies; Modest, Dominik P; Algül, Hana; Stintzing, Sebastian; Heinemann, Volker; Holch, Julian W.
Afiliação
  • Liu L; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.
  • Erickson NT; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.
  • Ricard I; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.
  • von Weikersthal LF; Gesundheitszentrum St Marien, Amberg, Germany.
  • Lerch MM; Klinik und Poliklinik für Innere Medizin A, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Decker T; Studienzentrum Onkologie Ravensburg, Ravensburg, Germany.
  • Kiani A; Klinikum Bayreuth GmbH, Bayreuth, Germany.
  • Kaiser F; Praxis Hämatologie/Onkologie/Palliativmedizin-Tagesklinik, Landshut, Germany.
  • Heintges T; VK&K Studien GbR, Landshut, Germany.
  • Kahl C; Lukaskrankenhaus Neuss, Neuss, Germany.
  • Kullmann F; Städtisches Klinikum Magdeburg, Hämatologie/ Onkologie, Magdeburg, Germany.
  • Scheithauer W; Klinikum Weiden, Medizinische Klinik I, Weiden, Germany.
  • Link H; Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Höffkes HG; Department of Medicine I, Westpfalz-Klinikum GmbH, Kaiserslautern, Germany.
  • Moehler M; Klinikum Fulda, Tumorklinik, Fulda, Germany.
  • Gesenhues AB; Medical Department 1, Johannes-Gutenberg Universität Mainz, Mainz, Germany.
  • Theurich S; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Michl M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Modest DP; Cancer- and Immunometabolism Research Group, Gene Center LMU Munich, Munich, Germany.
  • Algül H; German Cancer Consortium (DKTK), Partner Site Munich and German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Stintzing S; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.
  • Heinemann V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Holch JW; Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.
Int J Cancer ; 150(1): 112-123, 2022 01 01.
Article em En | MEDLINE | ID: mdl-34431518

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Redução de Peso / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Redução de Peso / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha